TrialBritish journal of cancer2002

A phase I/II study of 4 monthly courses of high-dose cyclophosphamide and thiotepa for metastatic breast cancer patients.

T Bachelot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.